Celldex Therapeutics Inc (CLDX)
Net Income Growth
-50.59%
TTM · Period ending:
CLDX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-50.59%period ending
Latest reported-50.59%period ending
CLDX TTM Net Income YoY % (78.57% → -50.59%)
Year-over-year change
High-resolution chart · PNG
CLDX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -50.5904% | |
| -58.6175% | |
| -63.9396% | |
| -45.7271% | |
| -32.8813% | |
| -23.4511% | |
| -11.62% | |
| -23.6474% | |
| -32.7771% | |
| -22.1181% | |
| -25.9105% | |
| -17.5721% | |
| -13.5268% | |
| -54.0267% | |
| -59.3014% | |
| -46.667% | |
| -50.9109% | |
| -20.9285% | |
| -17.9508% | |
| -49.5292% | |
| -45.0809% | |
| -37.6729% | |
| -17.4968% | |
| 3.0221% | |
| 0.3219% | |
| 8.0074% | |
| 66.347% | |
| 65.7794% | |
| 72.2823% | |
| 71.5713% | |
| -62.5093% | |
| -19.8573% | |
| -32.0776% | |
| -38.0774% | |
| 27.6192% | |
| 5.7483% | |
| 4.9943% | |
| 2.7169% | |
| -1.048% | |
| -2.0367% | |
| -7.2307% | |
| -11.2758% | |
| -7.721% | |
| -16.6293% | |
| -18.4341% | |
| -25.7435% | |
| -44.7946% | |
| -41.9765% | |
| -51.6221% | |
| -49.5432% | |
| -37.9328% | |
| -38.5972% | |
| -31.6433% | |
| -30.4273% | |
| -31.9739% | |
| -485.2435% | |
| -670.6145% | |
| -702.9285% | |
| -1,668.6143% | |
| 75.3363% | |
| 81.446% | |
| 83.0245% | |
| 93.0652% | |
| -22.8795% | |
| -14.9302% | |
| -7.0456% | |
| 23.1043% | |
| 31.4893% | |
| 24.4202% | |
| 3.2834% | |
| -195.0655% | |
| -165.5923% | |
| -125.1704% | |
| -59.5337% | |
| 20.9857% | |
| 5.9803% | |
| -8.0813% | |
| -32.3246% | |
| -12.5845% | |
| -1.832% | |
| -0.8088% | |
| -0.2244% | |
| -37.0568% | |
| -31.8305% | |
| -42.4544% | |
| -44.0958% | |
| -4.2164% | |
| -11.3494% | |
| -15.8826% | |
| 8.6424% | |
| 8.3859% | |
| 29.4791% | |
| 55.5354% | |
| 48.0927% | |
| 39.1944% | |
| 41.4284% | |
| 13.5651% | |
| 0.8464% | |
| -3.4962% | |
| -143.0273% |